Trials / Completed
CompletedNCT00382577
Efficacy and Safety of Itopride vs Placebo in Heartburn
A Randomized, Double-blind, Two Period, Crossover Study to Evaluate the Effects of a Single Dose of Itopride 200 mg on Esophageal and Gastric pH and Reflux in Patients With Heartburn
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Forest Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of itopride in patients with heartburn.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Itopride | |
| DRUG | Placebo |
Timeline
- Start date
- 2006-10-01
- Completion
- 2006-12-01
- First posted
- 2006-09-29
- Last updated
- 2017-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00382577. Inclusion in this directory is not an endorsement.